Cornflower (Centaurea cyanus L.): A Comprehensive Reference
1. Identity, Botanical Classification, and Nomenclature
Centaurea cyanus L., commonly known as cornflower, is an annual plant of the Asteraceae family, probably native to the Eastern Mediterranean region and historically a common weed of cereal crops. Its accepted synonym is Cyanus segetum Hill, an annual Asteraceae species that grows in many countries throughout Europe and Asia.
Common names include bachelor's button, cornflower, and blue-bottle. Additional vernacular names documented across European languages include blueblow, blue cap, blue poppy, bluebonnets, kornblomst (Danish), Kornblume (German), blåklint (Swedish), bleuet and casse lunette (French). The French name casse-lunettes ("glasses-breaker") reflects its long-standing association with eye care in French folk medicine.
The epithet Centaurea is assonant with the Greek kéntauros (centaur), a mythological figure half man and half horse; according to some authors, this genus is dedicated to Chiron, a centaur expert in science and medicine, considered the teacher of Aesculapius, Achilles, and other heroes. The species name cyanus is Botanical Latin taken from the Ancient Greek kúanos, meaning "dark blue," as a reference to the color of the flowers.
The cornflower is scientifically classified as Centaurea cyanus, belonging to the Asteraceae family, which also includes daisies and sunflowers. It grows as a slender annual, typically reaching 20 to 100 centimeters tall on grey-green, branched stems. The foliage consists of narrow, lanceolate leaves covered in fine, matted hairs, giving the plant a slightly greyish-green appearance. The flower structure is a composite head, known as a capitulum, characteristic of the Asteraceae family. Each flowerhead measures approximately 1.5 to 3 centimeters across and is composed of two distinct types of florets: a ring of larger, funnel-shaped, sterile ray florets surrounds a central cluster of smaller, fertile disc florets.
Cornflowers feature a distinctive appearance: their flowers are typically a deep blue, though they can also be found in shades of pink, purple, and white due to cultivated varieties. This flowering weed is commonly noticeable next to cornfields due to an intensive blue colour provided by a supramolecular pigment called protocyanin.
Although its initial distribution was centred in the Eastern Mediterranean region, C. cyanus has spread to Europe, North America, and Asia. However, intensive farming practices have caused a significant decline in its populations. The species Centaurea cyanus L. is included in the Russian Federation's current pharmacopeia; its flowers are used as a diuretic. The cornflower is also listed in the French Pharmacopoeia, and the virtues of the cornflower were first mentioned in the 12th century by Saint Hildegard of Bingen.
2. Traditional and Historical Use
Cornflower has a well-documented history of medicinal and culinary use across European traditions, extending back to antiquity.
2.1 European Folk and Herbal Medicine
Centaurea cyanus L. (Asteraceae) flower-heads are a well-known crude drug used in European traditional medicine in the treatment of minor ocular inflammation. This ophthalmic tradition drew partly on the medieval "doctrine of signatures" — the striking blue color of the flower being taken as an indication of benefit to the eyes. According to the "doctrine of signatures," the cornflower floral water would be a remedy for eye problems such as stye, conjunctivitis, and irritated eyes, and would symbolize a view "as clear as a cloudless sky."
Cornflower is indigenous to the Mediterranean region and has been naturalized all over Great Britain, where it was widespread in grain fields; farmers viewed this plant as a weed and referred to it as "hurtsickle" owing to its sturdy stem that unsharpened their sickles.
With its content of bioactive substances, this plant is reported to have anti-inflammatory, antimicrobial, antipruritic, antitussive, astringent, cholagogic, diuretic, emmenagogue, gastroprotective, immunological, ophthalmic, purgative and many other biological activities in traditional use.
A decoction prepared with the dehydrated cornflower has been used traditionally to treat inflammation of the eyes. In traditional medicine, the leaves or the seeds soaked in wine were taken internally to treat pestilential fevers.
Medicinal properties have also been detected in seeds, which are used as mild laxatives; leaves used for production of cleansing facial spray and decoction with antirheumatic activity; and stems, which exhibit antibacterial activity.
2.2 Traditional Use in Turkey and Russian Medicine
In traditional Turkish medicine, various species of the genus Centaurea are utilized to address a range of ailments, including illness and inflammation, symptoms associated with rheumatoid arthritis, fever, and headache. Centaurea cyanus L. is also used as a diuretic and tonic in Scottish medicine.
2.3 Cultural and Cosmetic Uses
Beyond medicinal applications, cornflower petals have adorned European festivals and celebrations for centuries. The vibrant blue petals were woven into garlands, scattered at weddings, and used to decorate homes during special occasions. Their striking color made them a natural choice for adding visual appeal to potpourris and as a natural fabric dye for textiles.
The flowers of Centaurea cyanus are used in traditional medicine in the form of aqueous extract. Herbal infusions (teas) of dried flower heads represent one of the oldest and most widespread traditional preparations.
3. Common Forms and Preparations
Cornflower is commercially available and used in several distinct preparations:
- Dried flower heads (herbal tea / infusion): The most traditional form. Dried funnel-shaped and tubular flowers are prepared as a hot-water infusion or decoction for internal use.
- Aqueous and hydroalcoholic extracts: This plant has long been known for its medicinal properties and is widely used in both traditional and official medicine. In medicinal practice, funnel-shaped and tubular flowers of cornflower are mainly utilized due to their pronounced anti-inflammatory, diuretic, antibacterial, immunomodulatory, antioxidant, and capillary-strengthening effects, making them effective for cardiovascular disease prevention.
- Floral water (hydrosol): The floral water of cornflower, or hydrosol, is obtained through steam distillation of cornflower blossoms. The cornflower is notably renowned for its hydrosol (INCI name: Centaurea Cyanus Flower Water), which is widely used in skincare, particularly in the composition of eye lotions, due to its medicinal and cosmetic indications.
- Flower extract (cosmetic-grade): Standardized extracts of the flower capitula are used in skincare formulations, eye creams, and cleansers.
- Polysaccharide and polyphenol fractions: Researchers have isolated and tested discrete polysaccharide and polyphenol fractions for pharmacological purposes, particularly in gastroprotection studies.
- Culinary use: Fresh or dried petals are used as edible garnishes and natural food colorants.
4. Key Constituents and Active Compounds
Chemical analysis of different parts of Centaurea cyanus revealed that the plant contained flavonoids, anthocyanins, phenylpropanic compounds, aromatic acids, phenolcarboxylic acids, amino acids, sugars, indole alkaloids, and was rich in minerals and trace elements.
4.1 Flavonoids
Twelve non-anthocyanin flavonoids — including apigenin, quercetin, kaempferol, eriodictyol, and taxifolin derivatives — have been identified in C. cyanus. Flavonoids are associated with antioxidant activity, capillary protection, and anti-inflammatory properties.
4.2 Anthocyanins and Protocyanin
Four cyanidin derivatives have been identified in the flowers. This flowering weed is commonly noticeable next to cornfields due to an intensive blue colour provided by a supramolecular pigment called protocyanin. Protocyanin is a metal-anthocyanin complex; the metal-anthocyanin complex maintains the stable blue colour in the petals of the flowers because if the pH is slightly acid, the colour of the pigments is red-purple.
4.3 Phenolic and Hydroxycinnamic Acids
Chlorogenic, caffeic, ferulic, and p-coumaric acids, isoquercitrin, and coumarin have been identified as the major compounds in optimised extracts. These hydroxycinnamic acid derivatives contribute to the plant's antioxidant and antimicrobial properties.
4.4 Polysaccharides
Polysaccharides extracted from C. cyanus flower-heads have been found to have anti-inflammatory properties and to interfere with complement. These polysaccharides were found to be mainly composed of galacturonic acid, arabinose, glucose, rhamnose and galactose. These complex carbohydrates are also implicated in gastroprotective activity.
4.5 Coumarins and Tannins
Coumarins have been identified among the chemical compounds in organic extracts of C. cyanus petals, alongside hydroxycinnamic acids, flavonoids, and polysaccharides. Tannins present in the plant are responsible for its astringent properties.
4.6 Sesquiterpenes, Organic Acids, and Minerals
Centaurea cyanus contains soluble sugars such as fructose, glucose, and sucrose, as well as organic acids including oxalic, quinic, malic, shikimic, citric acid, and traces of fumaric acid. C. cyanus harbors a diverse array of potentially relevant bioactive constituents, including polysaccharides, polyphenols, flavonoids, and sesquiterpenes, documented in the literature.
4.7 Notable Isolated Compound: Graveobioside A
Docking analysis has suggested cannabinoid receptors (CB) 1 and 2 as potential targets of cornflower compounds. Specifically, graveobioside A from the cornflower water extract inhibited CB1 and upregulated CB2, subsequently stimulating protein synthesis and suppressing degradation.
5. Established and Proposed Mechanisms of Action
The pharmacological activities attributed to Centaurea cyanus arise from the collective and, in some cases, synergistic activity of its constituent compound classes.
- Complement inhibition: Polysaccharides extracted from C. cyanus flower-heads have anti-inflammatory properties and interfere with complement, as demonstrated by inhibition of carrageenan-, zymosan-, and croton oil-induced oedemas, inhibition of plasma haemolytic activity, and induction of anaphylatoxin activity.
- Antioxidant mechanisms: Inhibition of lipid peroxidation, antioxidant activity, and anti-hemolytic activity have been measured using standardized assays.
- Gastroprotective mechanisms: In vivo pharmacological studies revealed high influence of a combined polysaccharide and polyphenol (PA) product at 500 mg/kg body weight on deep, moderate, and superficial gastric mucosal lesions, greater than that of ranitidine. The polysaccharide product was proven more effective than ranitidine in opposing the emergence of deep necrotic lesions, suggesting the ability of polysaccharides to consolidate the gastric mucous layer.
- Cannabinoid receptor modulation: A cornflower water extract and its isolated compounds mitigated oxidative stress, promoted myofiber growth, and boosted ATP production in muscle cell models. Mechanistically, the extract reduced protein degradation markers, increased mitochondrial content, and activated protein synthesis signaling.
- Anti-hemolytic activity: The extract of the non-edible part of the capitulum was more efficient in inhibiting the formation of thiobarbituric acid reactive substances (TBARS), the bleaching of β-carotene, and the haemolysis of the erythrocyte membrane.
6. Scientific Evidence by Area of Use
6.1 Ocular Inflammation and Eye Care
This is the area for which C. cyanus has the longest and most consistent traditional and pharmacological documentation in Europe.
Centaurea cyanus flower-heads are used in European phytotherapy for the treatment of minor ocular inflammations. Different pharmacological experiments — inhibition of carrageenan-, zymosan-, and croton oil-induced oedemas, inhibition of plasma haemolytic activity, induction of anaphylatoxin activity — showed that polysaccharides extracted from C. cyanus flower-heads had anti-inflammatory properties and interfered with complement.
There are no clinical (human) studies at this stage confirming the anti-inflammatory properties directly derived from the cornflower. However, various experiments conducted on rat serum have shown that the water-soluble extract obtained from the flower-heads of Centaurea cyanus has anti-inflammatory properties by interfering with the complement system, after inducing different inflammatory states.
Evidence strength: The ophthalmic use is well-established in traditional European medicine and is supported by in vitro and animal (rat) pharmacological data. No randomized controlled clinical trials in humans have been published confirming efficacy for ocular inflammation specifically. The evidence remains preclinical.
6.2 Anti-inflammatory Activity
Research has validated traditional anti-inflammatory uses of cornflower. A study published in the Journal of Ethnopharmacology demonstrated that polysaccharides extracted from Centaurea cyanus flower-heads exhibited significant anti-inflammatory properties, showing these polysaccharides could inhibit carrageenan-induced edema, zymosan-induced inflammation, and croton oil-induced tissue swelling. The mechanism of action appears to involve interference with the complement system, a crucial part of the innate immune response.
Evidence strength: Preclinical only (animal models). No human clinical trials on anti-inflammatory outcomes have been published.
6.3 Antioxidant Activity
One study aimed to optimize the extraction of phytochemical compounds and functional properties of Centaurea cyanus petals, determining chemical composition via LC-ESI-MS/MS, the effects of pH on the stability and antioxidant activity of anthocyanins, the inhibition of lipid peroxidation, antioxidant activity, and anti-hemolytic activity. Results showed that temperature and time influenced the content of flavonoids, anthocyanins, and FRAP; only temperature influenced total phenolic content, non-anthocyanin flavonoids, and antioxidant activity (DPPH).
Evidence strength: In vitro laboratory data only. No human clinical trials on antioxidant endpoints have been conducted with C. cyanus.
6.4 Gastroprotective Activity
Work aimed at testing gastroprotective effects of Centaurea cyanus L. polysaccharide (P) and polyphenol (A) fractions in a stress-induced rat ulcer model, alongside evaluation of acute toxicity, antioxidant, and antimicrobial activities, found that in vivo pharmacological studies revealed a high influence of the combined PA product (500 mg/kg body weight) on deep, moderate, and superficial gastric mucosal lesions, greater than that of the chemical reference ranitidine.
The polysaccharide product alone was proven more effective than ranitidine in opposing the emergence of deep necrotic lesions only, suggesting the ability of polysaccharide compounds to consolidate the gastric mucous layer as well as their certain tendency for cooperation with polyphenol fractions.
Evidence strength: Animal (rat) model data only. No human clinical data available.
6.5 Antimicrobial Activity
In general, extracts from the cornflower capitulum were more active against Gram-positive bacteria and had no cytotoxicity against non-tumour liver PLP2 cells. Studies evaluating antimicrobial activities on Staphylococcus aureus ATCC6538 and Escherichia coli ATCC8739 strains of the combined polysaccharide-polyphenol product have been conducted.
Evidence strength: In vitro data only. Antimicrobial activity has been demonstrated in cell culture settings but not in clinical trials.
6.6 Anti-hypertensive Activity
An optimized petal extract presented anti-hemolytic and anti-hypertensive activity in vitro, in addition to showing stability and reversibility of anthocyanins and antioxidant activity with pH variation.
Evidence strength: In vitro only. No human studies on blood pressure outcomes have been published.
6.7 Muscle Atrophy and Sarcopenia
A recent study from the Korea Institute of Science and Technology investigated the potential of cornflower against glucocorticoid-induced muscle wasting. Sarcopenia, a decline in muscle mass and strength, can be triggered by aging or medications like glucocorticoids. This study investigated a cornflower (Centaurea cyanus) water extract (CC) as a potential protective agent against dexamethasone-induced muscle wasting in vitro and in vivo. CC and its isolated compounds mitigated oxidative stress, promoted myofiber growth, and boosted ATP production in C2C12 myotubes. Mechanistically, CC reduced protein degradation markers, increased mitochondrial content, and activated protein synthesis signaling.
Evidence strength: Preliminary in vitro and animal study. No human clinical evidence exists for this application.
6.8 Antidiabetic Potential
Various phytochemicals in Centaurea species — including alkaloids, sesquiterpenes, saponins, polysaccharides, flavonoids, dietary fibers, ferulic acid, tannins, and others — have been studied for their inhibitory activity toward enzymes involved in the onset and progression of type 2 diabetes mellitus.
Evidence strength: Entirely preclinical; the available data are from in vitro enzyme inhibition assays and are limited to the broader Centaurea genus, not specifically C. cyanus in controlled trials.
6.9 Cytotoxic Activity
The C. cyanus petals aqueous extract exhibited high IC50 and GI50 values (>900 μg/mL) for all cell lines tested, meaning low cytotoxicity. Based on the stress oxidative assay, the extract exhibited a pro-oxidant action at 10–100 μg/mL but did not cause damage or cell death.
Evidence strength: In vitro only. The low cytotoxicity finding is relevant to the safety profile of the aqueous extract for human use, though it does not constitute clinical evidence of anticancer efficacy.
7. Body Systems Associated with Cornflower
Based on the accumulated traditional use and laboratory research, Centaurea cyanus has been associated with the following body systems:
- Ocular / Ophthalmic system: Funnel-shaped and tubular flowers are mainly utilized in medicinal practice due to their pronounced anti-inflammatory, diuretic, antibacterial, immunomodulatory, antioxidant, and capillary-strengthening effects. The strongest traditional evidence base exists for ophthalmic use.
- Gastrointestinal system: Gastroprotection via polysaccharide and polyphenol fractions; traditional use as a diuretic and mild laxative.
- Immune / Inflammatory system: Complement system modulation via polysaccharides; broad anti-inflammatory activity documented preclinically.
- Cardiovascular and vascular system: In vitro anti-hypertensive effects; flavonoid-associated capillary-strengthening properties.
- Musculoskeletal system: Emerging preclinical evidence for protection against glucocorticoid-induced muscle wasting via cannabinoid receptor pathways.
- Skin / Integumentary system: Traditional astringent, anti-inflammatory, and anti-edemic use; modern cosmetic applications via floral water.
- Urinary system: The species Centaurea cyanus L. is included in the Russian Federation's current pharmacopeia; its flowers are used as a diuretic.
8. Dosage Forms and Reported Dosages
Clinical dosage data for Centaurea cyanus are sparse, as no large-scale randomized controlled trials in humans have been conducted. The following dosages appear in the scientific and pharmacological literature:
- Gastroprotection (animal study): In a rat stress-ulcer model, fasted animals received the selective polysaccharide product (P) orally at 500 mg/kg of body weight, one hour before the stress experiment. The combined PA product was used at the same dose.
- Eye drops (traditional pharmacopeial combination product): An eye drops solution documented in EMA assessment literature includes Centaurea cyanus flower at 0.05 mL/mL as a component.
- Herbal tea / infusion: No specific human dosage has been established in peer-reviewed literature for internal use. Traditional European practice involved infusions of dried flower heads, though no standardized dose has been confirmed in clinical trials.
- Floral water (hydrosol): The floral water hydrosol is obtained through steam distillation of cornflower blossoms and can be used alone or combined with other skin-active ingredients in topical applications. No standardized dermatological dosing schedule exists in the peer-reviewed literature.
9. Safety Considerations
9.1 Asteraceae / Compositae Family Allergy
Sesquiterpene lactones (SLs) present in Asteraceae plants may cause sensitization resulting in skin irritation and inflammation. Asteraceae-related allergy symptoms can involve eczema, hay fever, asthma, or even anaphylaxis.
Cross-reactions have been observed among other Asteraceae species including Tussilago farfara L., Centaurea cyanus L., Cirsium arvense, and Solidago virgaurea. This means that individuals with documented sensitivity to other Asteraceae (such as chamomile, arnica, or ragweed) may also react to cornflower products.
Exposure to Asteraceae-containing cosmetic products may lead to dermatitis, though this is highly dependent on the particular plant species involved.
Allergic symptoms have been reported from ingested Compositae herbs; case reports have described angioedema, urticaria, and systemic contact dermatitis.
9.2 Contact Dermatitis and Sesquiterpene Lactone Sensitivity
Almost 50% of sesquiterpene lactones are potential contact allergens. These metabolites are present both in fresh and dried plants in various proportions from 0.01 to 8% per dry weight.
The most common cutaneous finding is localized vesicular or eczematous patches on the hands or wrists. Other variations include eczematous rashes on the exposed skin of the hands, arms, face, and neck; generalized eczema; and isolated facial eczema, which can be attributed to contact dermatitis caused by airborne pollen.
9.3 Low Cytotoxicity of Aqueous Extract
The C. cyanus petals aqueous extract exhibited high IC50 and GI50 values (>900 μg/mL) for all cell lines tested, indicating low cytotoxicity. This finding, from an in vitro study, provides some preliminary evidence that the aqueous petal extract does not readily damage non-tumour cells at concentrations tested, though in vitro findings do not directly predict human safety.
9.4 Pharmacopeial Status and Pregnancy / Emmenagogue Use
The plant is reported to have emmenagogue activity in traditional European literature, which historically indicates caution regarding use during pregnancy. However, no clinical safety studies evaluating effects in pregnancy are available in the peer-reviewed literature.
9.5 Absence of Known Drug Interactions in Peer-Reviewed Literature
No peer-reviewed human pharmacokinetic studies or formal interaction studies between Centaurea cyanus preparations and pharmaceutical drugs have been published as of the current literature. The in vitro anti-hypertensive activity noted in one study raises theoretical questions about additive effects with antihypertensive medications, but no clinical evidence supports or refutes this.
10. Regulatory and Pharmacopeial Status
The species Centaurea cyanus L. is included in the Russian Federation's current pharmacopeia; its flowers are used as a diuretic. The cornflower is listed in the French Pharmacopoeia. In the European Union, Centaurea cyanus flower water appears as a recognized cosmetic ingredient under the INCI system and has been referenced in EMA assessment literature for multi-component herbal ophthalmic formulations. No standalone EMA Community Herbal Monograph for Centaurea cyanus has been published as a single-herb medicine.
Summary of Evidence Quality
The totality of scientific evidence on Centaurea cyanus is predominantly preclinical (in vitro and animal model studies). The different parts of the plant have been shown in laboratory and animal studies to exert pharmacological activities including antimicrobial, nervous system, dermatological, anti-inflammatory, cytotoxic, antioxidant, hypolipidemic, antihemorrhagic, hemolytic, and many other effects. However, no published randomized controlled clinical trials in humans confirm efficacy for any specific health indication as of the current literature. The most pharmacologically substantiated traditional use — treatment of minor ocular inflammation — is supported by mechanistic animal data but lacks human clinical trial verification. All other proposed health benefits remain at the level of in vitro or animal research and should be considered preliminary.
References
Go back